Esophageal motility disorders – The Chicago classification, v3.0
Review articleGastroent Hepatol 2015; 69(2): 130–138. doi:10.14735/amgh2015130
SummaryLiteraturepdf Rudolf Hyrdel, Peter Bánovčin, Martin ĎuričekTherapy of chronic hepatitis C with simeprevir
Review articleGastroent Hepatol 2015; 69(2): 103–108. doi:10.14735/amgh2015103
SummaryLiteraturepdf Petr UrbánekNovel oral anticoagulants – the advantages and drawbacks of the therapy
Review articleGastroent Hepatol 2015; 69(2): 152–160. doi:10.14735/amgh2015152
SummaryLiteraturepdf Jan BultasNoninvasive diagnostics in NAFLD
Review articleGastroent Hepatol 2015; 69(2): 110–115. doi:10.14735/amgh2015110
SummaryLiteraturepdf Karel DvořákSmall intestinal bacterial overgrowth syndrome
Review articleGastroent Hepatol 2015; 69(1): 70–72. doi:10.14735/amgh201570
SummaryLiteraturepdf Ladislav KuželaA practical contribution to the diagnostics and treatment of focal nodular hyperplasia and adenomas in the liver from the perspective of a hepatologist, radiologist, pathologist and surgeon
Review articleGastroent Hepatol 2015; 69(1): 56–64. doi:doi: 10.14735/amgh201556
SummaryLiteraturepdf Halima Gottfriedová, Eva Honsová, Darina Cupalová, Dana Kautznerová, Lucie Morávková, Pavel Trunečka, Julius Špičák, Martin OliveriusImmunoablative therapy and autologous hematopoietic stem cell transplantation in a patient with aggressive Crohn’s disease refractory to medical therapy
Review articleGastroent Hepatol 2015; 69(1): 50–54. doi: doi: 10.14735/amgh201550
SummaryLiteraturepdf Veronika Hrubá, Dana Ďuricová, Šárka Rahmatová, Naděžda Machková, Martin Bortlík, Martin Lukáš, Milan Lukáš, Katarína Mitrová, Martin Horák, Tomáš Kozák, Jan NovákThe importance of fecal calprotectin in the diagnostics and treatment of inflammatory bowel diseases
Review articleGastroent Hepatol 2015; 69(1): 43–49. doi:doi: 10.14735/amgh201543
SummaryLiteraturepdf Juraj Letkovský, Tibor HlavatýTopical treatment of inflammatory bowel diseases
Review articleGastroent Hepatol 2015; 69(1): 38–42. doi:doi: 10.14735/amgh201538
SummaryLiteraturepdf Tomáš DoudaVedolizumab in the therapy of ulcerative colitis patients
Review articleGastroent Hepatol 2015; 69(1): 29–32. doi:10.14735/amgh201529
SummaryLiteraturepdf Milan Lukáš